Featured series 
Tag: Cancer
-
Health
“Good” cells can go “bad” in a “bad neighborhood”
Normal.dotm 0 0 1 375 2142 Harvard University 17 4 2630 12.0 0 false 18 pt 18 pt 0 0 false false false The general theory of cancer development holds…
-
Campus & Community
Second opinions, anywhere
Rwanda has 10 million people, but no cancer specialists. A recent collaboration between a Waltham medical information company and a Harvard University research institute aims to reduce such professional isolation – and to learn from the medical knowledge and resourcefulness of doctors in the developing world.
-
Campus & Community
Stem Cell Experiment Reverses Aging In Rare Disease
The team at Children’s Hospital Boston and the Harvard Stem Cell Institute were working with a new type of cell called induced pluripotent stem cells or iPS cells, which closely resemble embryonic stem cells but are made from ordinary skin cells…
-
Health
The hunt for healthy answers
JoAnn Manson leads a nationwide study to assess whether vitamin D and omega-3 fatty acids can boost immunity and protect against ailments from heart disease to cancer.
-
Campus & Community
Daffodil Days in full bloom
At Harvard, the month of February brings the promise of spring with the kick-off of Daffodil Days, a University-wide effort to raise funds to support the fight against cancer.
-
Health
Genes linked to breast cancer drug resistance
Harvard researchers at the Dana-Farber Cancer Institute have discovered a “gene activity signature” that predicts a high risk of cancer recurrence in some breast tumors that have been treated with…
-
Health
Want to live well?
Harvard faculty members from a range of fields give tips on how to live healthy.
-
Health
Cancer vaccine success
A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week (Nov. 25) in the journal Science Translational Medicine.
-
Health
First cancer vaccine to eliminate tumors in mice
A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, a team of Harvard bioengineers and biologists report…
-
Health
Researchers ‘NOTCH’ a victory in war on cancer
Normal 0 0 1 819 4673 38 9 5738 11.1282 0 0 0 Scientists have devised an innovative way to disarm a key protein considered to be “undruggable,” meaning that…
-
Health
Darkness with the light
Adult survivors of childhood cancer have an increased risk of suicidal thoughts, even decades after their cancer treatments have ended, according to a study led by Harvard researchers at Dana-Farber…
-
Campus & Community
A Cancer Visible To The Naked Eye, But Doctors Aren’t Looking
“We were very, very surprised,” Geller recalls. “About three-quarters of them were never trained in the skin cancer exam, and more than half never once practiced the examination during their primary care residency.” Geller, who’s a senior research scientist at the Harvard School of Public Health, says those high levels of inexperience are really worrisome.…
-
Campus & Community
Study Finds Pro and Cons to Prostate Surgeries
People intuitively think that a minimally invasive approach has fewer complications, even in the absence of data,” said Dr. Jim C. Hu, the study’s lead author, who is director of urologic robotic and minimally invasive surgery at Brigham and Women’s Hospital in Boston.
-
Campus & Community
U.S. study shows mammograms save lives
“The most effective method for women to avoid death from breast cancer is to have regular mammographic screening,” Dr. Blake Cady of Cambridge Hospital Breast Center and Harvard Medical School in Massachusetts told reporters in a telephone briefing…
-
Campus & Community
Telomerase work wins Szostak Nobel Prize in medicine
Jack W. Szostak, a genetics professor at Harvard Medical School and Harvard-affiliated Massachusetts General Hospital (MGH), has won the 2009 Nobel Prize in physiology or medicine for work on cellular structures called telomeres, which protect chromosomes from degradation.
-
Campus & Community
Aspirin Can Prevent Colon Cancer in High-Risk Group, Study Says
The Harvard study suggested aspirin could prevent tumors from growing by inhibiting Cox-2, an enzyme that may play a role in the initial growth of a tumor.
-
Campus & Community
Diabetes Medication May Get New Life as Cancer Treatment
A national tax of 1 cent per ounce of soda and other sugary drinks could stem the United States’ obesity epidemic, while generating $14.9 billion the first year alone, health experts say.
-
Campus & Community
Does Infection Boost Prostate Cancer Risk?
In the new study, Jennifer Stark of the Harvard School of Public Health in Boston and colleagues analyzed blood samples from 673 men with prostate cancer who participated in the Physicians’ Health Study, a large, ongoing study examining a variety of health issues.
-
Health
New metabolic safeguards against tumor cells revealed
Cells don’t like to be alone. In the early stages of tumor formation, a cell might be pushed out of its normal home environment due to excessive growth. But a…
-
Health
Study supports DNA repair-blocker research in cancer therapy
Scientists at Dana-Farber Cancer Institute have uncovered the mechanism behind a promising new approach to cancer treatment: damaging cancer cells’ DNA with potent drugs while simultaneously preventing the cells from…
-
Health
Researchers discover chemical that kills cancer stem cells
A multi-institutional team of Boston-area researchers has discovered a chemical that works in mice to kill the rare but aggressive cells within breast cancers that have the ability to seed…
-
Health
Postdiagnosis aspirin use reduces risk of dying from colorectal cancer
Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death, report Harvard researchers at Massachusetts General Hospital (MGH), Dana-Farber Cancer Institute (DFCI) and Brigham and Women’s Hospital. In today’s edition of the Journal of the American Medical Association, the study’s authors also find that the aspirin-associated survival advantage was seen…
-
Health
An unusual collection: A brain tumor tissue bank
Five years ago, as she was walking into Caritas Holy Family Hospital and Medical Center in Methuen, Mass., Patricia Fay saw a priest she knew and cornered him. “I’m like…
-
Health
Damon Runyon Cancer Research Foundation awards fellowships to Harvard scientists
The Damon Runyon Cancer Research Foundation, a nonprofit organization focused on supporting exceptional early career researchers and innovative cancer research, has selected four Harvard affiliates to receive Damon Runyon fellowships at its May 2009 Fellowship Award Committee review.
-
Health
First molecular steps to childhood leukemia identified
A Harvard research based at Massachusetts General Hospital has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL) – the most common cancer in children…
-
Health
Study pinpoints novel cancer gene and biomarker
Dana-Farber Cancer Institute scientists’ discovery of a cancer-causing gene – the first in its family to be linked to cancer – demonstrates how the panoramic view of genomics and the…
-
Campus & Community
I. (Israel) David Todres
(Israel) David Todres, Professor of Paediatrics (Anaesthesia) at Harvard Medical School, died at his home of lymphoma on Sept. 26, 2008. He was 73.
-
Health
AML patients benefit from stem cell transplants
A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute…
-
Health
DFCI cancer research highlights age-related treatment effectiveness, patient cost concerns
New research from the Dana-Farber Cancer Institute highlights age-related responses to colon cancer treatment and patient attitudes toward cost of drugs to manage side effects. Research presented at the American…